Privacy Policy
Signals Blog

Contributors

Categories

Nicole Kuchinsky

Nicole Kuchinsky is responsible for internal commercial operations and industry engagement at CCRM. A strong grounding in academic research helps her to understand the science behind new technologies in cell and gene therapy that CCRM is working to commercialize. Dr. Kuchinsky obtained her Master’s degree from the University of Toronto (U of T) in the Department of Zoology and continued graduate studies at U of T in the Department of Cell and Systems Biology, where she completed a PhD in developmental neurobiology under the supervision of Dr. Vince Tropepe. Dr. Kuchinsky went on to pursue studies in translational science with Dr. Michael Fehlings at the Krembil Research Institute in Toronto. Her post-doctoral work focused on animal models of spinal cord injury and cell based therapy for spinal cord regeneration. Nicole’s interest in science communication started early, with an undergraduate double major in English and Biology from Wilfrid Laurier University. Now she focuses her writing on anything and everything related to regenerative medicine technology. Follow Nicole on Twitter @DrNKuchinsky.

Posts by: Nicole


Skin stem cells provide hope for treating burn victims

Author: Nicole Kuchinsky, 11/03/15

At one point or another we’ve all experienced a bad haircut. We get over such minor annoyances secure in the knowledge that “it will grow back.” The ability of our hair to grow back is based on the amazing capacity of the hair follicle to undergo continuous cycles of growth and regrowth throughout our lifetime. […]

CRISPR/Cas9 gene editing: Is truth becoming stranger than fiction?

Author: Nicole Kuchinsky, 10/15/15

Last week, a Nature News article reported that the Harvard geneticist George Church had modified over 60 genes in pig embryos using CRISPR/Cas9 gene editing. I’m sure you’re expecting my scientific perspective on the significance of this news in the context of the excitement and controversy over CRISPR-Cas9 gene editing—and I will discuss that here. […]